Page last updated: 2024-10-24

cefixime and Paranasal Sinus Diseases

cefixime has been researched along with Paranasal Sinus Diseases in 1 studies

Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.

Paranasal Sinus Diseases: Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Trials

1 trial available for cefixime and Paranasal Sinus Diseases

ArticleYear
    Laryngo- rhino- otologie, 2017, Volume: 96, Issue:4

    Topics: Administration, Topical; Cefixime; Drug Therapy, Combination; Fluticasone; Follow-Up Studies; Furose

2017